CIK 0002002988
RTSN Retension Pharmaceuticals, Inc.
Insider trading from SEC Form 4. Last filing 4 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Signals
Open-market buys and sells at Retension Pharmaceuticals, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 3 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Michael J Berendt director | AGrant or award Stock Option (right to buy)derivative | +5,636 | $0.00 | $0 | 5,636 | 4 d ago |
| Oct 8, 2026 | Franklin M Berger director | AGrant or award Stock Option (right to buy)derivative | +5,636 | $0.00 | $0 | 5,636 | 4 d ago |
| Oct 8, 2026 | Donald Olds director | AGrant or award Stock Option (right to buy)derivative | +5,636 | $0.00 | $0 | 5,636 | 4 d ago |
Insiders
Everyone who has filed a Form 4 here.
- Michael J Berendtdirector
- Franklin M Bergerdirector
- Donald Oldsdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.